Eslit, Kevin .
HRN: 26-18-61 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/08/2024
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
11/08/2024
11/15/2024
IV
1.5g
Q8
Non Healing Wound
Waiting Final Action
Indication: Empiric Type of Infection: Bone & Joint Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes